Veracyte (VCYT) Total Current Liabilities (2012 - 2026)

Veracyte (VCYT) has 15 years of Total Current Liabilities data on file, last reported at $56.1 million in Q1 2026.

• Quarterly Total Current Liabilities fell 25.3% year-over-year to $56.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.1 million (down 25.3% YoY) and the FY2025 annual result came in at $59.9 million, down 23.78% from the prior year.
• Total Current Liabilities declined to $56.1 million in Q1 2026 per VCYT's latest filing, from $59.9 million in the prior quarter.
• The five-year high for Total Current Liabilities was $78.6 million in Q4 2024, with the low at $56.0 million in Q1 2023.
• Average Total Current Liabilities over 5 years is $64.4 million, with a median of $61.2 million recorded in 2023.
• Year-over-year, Total Current Liabilities jumped 91.21% in 2022 and dropped 25.3% in 2026.
• Veracyte's Total Current Liabilities stood at $62.6 million in 2022, then retreated by 2.19% to $61.2 million in 2023, then grew by 28.4% to $78.6 million in 2024, then retreated by 23.78% to $59.9 million in 2025, then declined by 6.38% to $56.1 million in 2026.
• Business Quant data shows VCYT's Total Current Liabilities at $56.1 million in Q1 2026, $59.9 million in Q4 2025, and $72.2 million in Q3 2025.